Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer with SOX Plus Tislelizumab Combined with HIPEC

NCT06760858 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT06760858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06760858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer with SOX Plus Tislelizumab Combined with HIPEC
Lead sponsor
Southwest Hospital, China
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2024
Completion date
September 1, 2029
Enrollment
122 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastroesophageal junction cancer